Lupin buys Dutch sterile injectable manufacturer Nanomi; Clearside Biomedical patents microneedle eye drug delivery;

> India's Lupin bought Dutch sterile injectable manufacturer Nanomi for an undisclosed amount. More from FiercePharmaManufacturing

> Clearside Biomedical snagged a patent for its microneedle drug delivery to the eye. More

> Intellipharmaceutics collected $3.1 million from Par Pharmaceuticals for its dexmethylphenidate hydrochloride extended-release capsules. More

> Analysts predict the microfluidics market will reach $3.5 billion by 2018, rising about 17% from $1.59 billion in 2013. Release

> Aegis collected a patent for the oral delivery of nucleotide-based drugs. Release

Suggested Articles

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.

Alexion's 100 mg/ml Ultomiris formulation is expected to slash infusion times by about 60% and bodes well for a planned subcutaneous version, too.

Kindeva, which produces inhalers, transdermal patches and other medical devices, is expanding operations in the St. Paul, Minnesota, area.